Stock 1763 CHINA ISOTOPE & RADIATION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials China Isotope & Radiation Corporation

Equities

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
10.82 HKD +5.25% Intraday chart for China Isotope & Radiation Corporation +16.97% -19.01%
Apr. 04 China Isotope & Radiation to Form JV Company MT
Apr. 03 China Network Group Co., Ltd. Enters into the Investment and Cooperation Agreement with CNNC Hainan Nuclear Power CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 4,354 6,017 7,242 5,734 3,780
Enterprise Value (EV) 1 1,877 4,115 5,398 3,802 1,716
P/E ratio 11.8 x 18.3 x 33.9 x 17.1 x 9.65 x
Yield 2% 0.74% 0.8% 2.11% 3.73%
Capitalization / Revenue 1.34 x 1.51 x 1.69 x 1.11 x 0.62 x
EV / Revenue 0.58 x 1.03 x 1.26 x 0.74 x 0.28 x
EV / EBITDA 2.8 x 5.34 x 7.48 x 4.22 x 1.63 x
EV / FCF -6.28 x -26.5 x -20 x 22.4 x 10.9 x
FCF Yield -15.9% -3.77% -4.99% 4.47% 9.14%
Price to Book 1.25 x 1.6 x 1.86 x 1.37 x 0.85 x
Nbr of stocks (in thousands) 319,875 319,875 319,875 319,875 319,875
Reference price 2 13.61 18.81 22.64 17.93 11.82
Announcement Date 4/26/19 4/28/20 4/20/21 4/27/22 4/26/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 2,672 3,238 3,989 4,274 5,144 6,146
EBITDA 1 577.6 670.3 770.3 721.6 901.4 1,054
EBIT 1 512.3 601.7 670 584.7 742.8 873.7
Operating Margin 19.17% 18.58% 16.8% 13.68% 14.44% 14.21%
Earnings before Tax (EBT) 1 558 693.1 733.8 596.2 802.7 920.5
Net income 1 271.5 323 329 213.6 335.8 391.6
Net margin 10.16% 9.97% 8.25% 5% 6.53% 6.37%
EPS 2 1.170 1.157 1.029 0.6677 1.050 1.224
Free Cash Flow 1 181.3 -299 -155.1 -269.3 169.8 156.9
FCF margin 6.78% -9.23% -3.89% -6.3% 3.3% 2.55%
FCF Conversion (EBITDA) 31.39% - - - 18.84% 14.88%
FCF Conversion (Net income) 66.78% - - - 50.58% 40.06%
Dividend per Share - 0.2726 0.1389 0.1803 0.3779 0.4407
Announcement Date 6/21/18 4/26/19 4/28/20 4/20/21 4/27/22 4/26/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 1,356 2,476 1,903 1,844 1,932 2,064
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 181 -299 -155 -269 170 157
ROE (net income / shareholders' equity) 24.3% 17.4% 13.4% 9.05% 11.7% 12%
ROA (Net income/ Total Assets) 7.73% 6.51% 5.32% 4.05% 4.72% 4.93%
Assets 1 3,510 4,964 6,187 5,269 7,109 7,946
Book Value Per Share 2 7.790 10.80 11.80 12.20 13.10 14.00
Cash Flow per Share 2 6.160 8.130 8.580 7.990 8.590 9.140
Capex 1 246 751 591 410 428 534
Capex / Sales 9.19% 23.19% 14.81% 9.59% 8.32% 8.69%
Announcement Date 6/21/18 4/26/19 4/28/20 4/20/21 4/27/22 4/26/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
CHINA ISOTOPE & RADIATION CORPORATION Stock China Isotope & Radiation Corporation
-19.01% 442M
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-10.29% 7.61B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.78% 5.41B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-1.16% 4.51B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+5.74% 4.49B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.70% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+12.21% 2.73B
VITROLIFE AB Stock Vitrolife AB
-16.13% 2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-11.50% 1.73B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 1763 Stock
  4. Financials China Isotope & Radiation Corporation